Cargando…
Construction and validation of a novel and superior protein risk model for prognosis prediction in esophageal cancer
Esophageal cancer (EC) is recognized as one of the most common malignant tumors in the word. Based on the biological process of EC occurrence and development, exploring molecular biomarkers can provide a good guidance for predicting the risk, prognosis and treatment response of EC. Proteomics has be...
Autores principales: | Liu, Yang, Wang, Miaomiao, Lu, Yang, Zhang, Shuyan, Kang, Lin, Zheng, Guona, Ren, Yanan, Guo, Xiaowan, Zhao, Huanfen, Hao, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705836/ https://www.ncbi.nlm.nih.gov/pubmed/36457747 http://dx.doi.org/10.3389/fgene.2022.1055202 |
Ejemplares similares
-
Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022) -
Rare pancreatic carcinosarcoma in a patient with medical history of esophageal cancer: A case report and literature review
por: Liu, Yang, et al.
Publicado: (2019) -
Primary synchronous colloid adenocarcinoma and squamous cell carcinoma in the same lung: A rare case report
por: Liu, Yang, et al.
Publicado: (2021) -
Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
por: Zheng, Ze-Jun, et al.
Publicado: (2022) -
Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)